SCOLR Pharma, Inc. (AMEX: DDD) today announced that it had acquired rights to the Nuprin® name in connection with sales ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE